Use of Bismuth Subsalicylate in Clostridium Difficile Colitis

NCT03592082 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Investigator left institution

Conditions

Clostridium Difficile Infection

Interventions

DRUG: Bismuth Subsalicylate
DRUG: standard antibiotic therapy

Sponsor

Bassett Healthcare